Varian Medical Systems, Inc. (VAR)
174.11 0.00 (0.00%)
After hours: 4:25PM EST
Chart Events
Performance Outlook
| Previous Close | 174.12 |
| Open | 174.10 |
| Bid | 174.05 x 1100 |
| Ask | 174.50 x 800 |
| Day's Range | 174.06 - 174.23 |
| 52 Week Range | 89.62 - 176.19 |
| Volume | 809,332 |
| Avg. Volume | 1,182,758 |
| Market Cap | 15.872B |
| Beta (5Y Monthly) | 1.17 |
| PE Ratio (TTM) | 59.22 |
| EPS (TTM) | 2.94 |
| Earnings Date | Jan 27, 2021 - Feb 01, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Dec 02, 1998 |
| 1y Target Est | 177.75 |
Fair Value
Related Research
- PR Newswire
Varian and the Cincinnati Children's/UC Health Proton Therapy Center Announce Initial Patient Treated in the FAST-01 First Human Clinical Trial of FLASH Therapy for Cancer
Varian (NYSE: VAR) and the Cincinnati Children's/UC Health Proton Therapy Center today announce the start of the first clinical trial of FLASH therapy as part of the recently opened FAST-01 study (FeAsibility Study of FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases). The clinical trial involves the investigational use of Varian's ProBeam® particle accelerator modified to enable radiation therapy delivery at ultra-high dose rates (dose delivered in less than 1 second) and is being conducted at the Cincinnati Children's/UC Health Proton Therapy Center with John C. Breneman M.D., Medical Director of the center, serving as principal investigator.
- GuruFocus.com
Top 5 3rd-Quarter Trades of Al Gore's Firm
Generation Investment Management releases quarterly portfolio
- PR Newswire
Varian Medical Systems Invests in COTA, Inc. to Help Drive Faster, More Accurate Data-Driven Cancer Care
Varian (NYSE: VAR) today announced a new $10M investment and collaboration agreement with COTA, Inc., a Boston-based curator of clinical data in oncology. Both companies will work together to empower cancer clinics with data analytics and decision support tools, using real-world evidence to help guide clinical and operational decisions as well as drive more cost-effective care.
